Is Pertuzumab Plus Trastuzumab Without Chemotherapy a Reasonable Treatment for ERBB2-Positive Metastatic Breast Cancer?-Reply
- PMID: 38329767
- DOI: 10.1001/jamaoncol.2023.6960
Is Pertuzumab Plus Trastuzumab Without Chemotherapy a Reasonable Treatment for ERBB2-Positive Metastatic Breast Cancer?-Reply
Comment on
-
Is Pertuzumab Plus Trastuzumab Without Chemotherapy a Reasonable Treatment for ERBB2-Positive Metastatic Breast Cancer?JAMA Oncol. 2024 Apr 1;10(4):537. doi: 10.1001/jamaoncol.2023.6957. JAMA Oncol. 2024. PMID: 38329744 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous